Please login to the form below

Not currently logged in
Email:
Password:

hepatic VOD

This page shows the latest hepatic VOD news and features for those working in and with pharma, biotech and healthcare.

Jazz Pharma bags FDA approval for rare disease drug

Jazz Pharma bags FDA approval for rare disease drug

Defitelio given the green light to treat patients who develop severe hepatic VOD. ... This is the first FDA-approved therapy for treatment of severe hepatic VOD, a rare and life-threatening condition that is seen in some patients who undergo high-dose

Latest news

  • Jazz offers $1bn for Italy's Gentium Jazz offers $1bn for Italy's Gentium

    The $57 per share deal gives Jazz an immediate boost in its ex-US business as well as access to Gentium's Defitelio (defibrotide) drug for the treatment of severe hepatic ... veno-occlusive disease (VOD) in adults and children undergoing hematopoietic

  • Gentium expects EMA rejection for defibrotide Gentium expects EMA rejection for defibrotide

    The Italy-based pharma company had applied for European approval of defibrotide to treat and prevent hepatic veno-occlusive disease (VOD) in adults and children undergoing hematopoietic stem cell transplantation therapy, ... VOD is a condition that

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics